Investigations into the use of recombinant Mdh1 as a candidate antigen for a candidiasis vaccine have demonstrated that subcutaneous and intradermal administration in mice elicits significantly elevated antibody responses and confers significant protection against candidiasis (Shibasaki et al., 2014). The gene discussed is MDH1; the disease is Candidiasis, Invasive.